Weight
CJC-1295 with DAC
Growth
29
Amino acids
Molecular weight
Peptide
Type
Modified growth hormone releasing hormone engineered for extended duration via albumin-binding technology. DAC binds to albumin, extending half-life and providing continuous GHRH receptor stimulation.
DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation.
Lyophilized: 2-8°C refrigerated; Reconstituted: 2-8°C refrigerated, use within 30 days
Once or twice weekly (e.g., Monday/Thursday for split dosing)
1-2mg weekly
8-12 weeks
Convenient weekly dosing
Sustained GH/IGF-1 elevation
6-8 day half-life
Significant body composition changes
This peptide is still gaining traction in the community.
Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release
This overview is informational and based on aggregated descriptions from studies and user reports.
Was it helpful?YesView the scientifc details of CJC-1295 with DAC.
29
Amino Acids
CJC-1295 with DAC
Tyr
Tyr
Position 1
Ala
Ala
Position 2
Asp
Asp
Position 3
Ala
Ala
Position 4
Ile
Ile
Position 5
Phe
Phe
Position 6
Thr
Thr
Position 7
Gln
Gln
Position 8
Ser
Ser
Position 9
Tyr
Tyr
Position 10
Arg
Arg
Position 11
Lys
Lys
Position 12
Val
Val
Position 13
Leu
Leu
Position 14
Ala
Ala
Position 15
Gln
Gln
Position 16
Leu
Leu
Position 17
Ser
Ser
Position 18
Ala
Ala
Position 19
Arg
Arg
Position 20
Lys
Lys
Position 21
Leu
Leu
Position 22
Leu
Leu
Position 23
Gln
Gln
Position 24
Asp
Asp
Position 25
Ile
Ile
Position 26
Leu
Leu
Position 27
Ser
Ser
Position 28
Arg
Arg
Position 29
Subcutaneous injection is the preferred route for DAC variant.
| Goal | Dosage | Frequency | Route |
|---|---|---|---|
| Conservative Anti-Aging | 1 | 1 week range | SubQ |
| Standard Protocol | 2 | 1 week range | SubQ |
| Split Dosing | 1 | 2 week range | SubQ |
| Loading Protocol | 2 | — | SubQ |
Materials needed:
Steps to reconstitute
The CJC-1295 with DAC Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.
Taking breaks between cycles may help maintain effectiveness and support better overall results.
Dosing tools
Calculate peptide doses with our visual syringe guide.
0.3mL / 30 units
5 units
0.050 mL
1 mL
2 mL
3 mL
5 mL
Custom
Conversion: 1,000 mcg = 1 mg
Based on your vial and dilution inputs.
CJC-1295 with DAC
SINGLE COMPOUNDVolume per injection
0.05
mL
Concentration
10.00
mg/mL
Doses per vial
20
doses
Total injections per vial
20 injections
How it works
Based on a 10 mg CJC-1295 with DAC vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.
Research Purposes Only
These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.
Note: Triple agonist; microdose for fewer side effects
Research suggestions of CJC-1295 with DAC interactions with other common peptides and substances.
Weight
cjc
Growth
AVOID
Never combine different variants; choose based on desired release pattern.
Weight
ipa
Growth
MONITOR
Continuous GH elevation may reduce synergistic benefits of pulsatile protocols.
Weight
mk6
Growth
AVOID
Both provide continuous GH elevation; combination risks excessive levels.
Weight
tesa
Growth
AVOID
Both are GHRH analogs; no additional benefit and potential receptor competition.
Avoid: Do not take CJC-1295 with DAC with CJC-1295 (without DAC), HGH, MK-677, Tesamorelin.
Monitor: Be careful when combining CJC-1295 with DAC with GHRP-6, Ipamorelin, Sermorelin.
Diabetes history
Cancer history
Predisposed sleep apnea
Severe joint pain or carpal tunnel syndrome
Excessive water retention affecting daily life
Numbness or tingling in extremities
Significant blood glucose dysregulation
Signs of acromegaly (jaw growth, hand/feet enlargement)
Persistent lethargy indicating adrenal effects
0.0
0 reviews
5
4
3
2
1
No comments yet
Be the first to share your experience. Your review helps others make more informed decisions.
Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.
Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.
Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.
Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.
Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.
Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.
Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.
Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.
CJC-1295 with DAC is a well studied compound
CJC-1295 with DAC
CJC-1295 with DAC is a well studied compound
Prolonged Growth Hormone Elevation with CJC-1295 DAC
12 subjects; sustained GH and IGF-1 elevation for 6-10 days post-injection with peak 2-4x baseline.
2006
Dose-Response Relationship of CJC-1295 DAC
48 subjects, 90 days. Optimal dosing 1-2mg weekly; dose-dependent IGF-1 increases but higher side effects above 2mg.
2008
Long-term Effects on GH/IGF-1 Axis
6-month animal model. Sustained IGF-1 elevation but evidence of reduced GH pulse amplitude suggesting desensitization.
2012
Comparative Pharmacokinetics: DAC vs Non-DAC Variants
DAC: 120-hour half-life vs non-DAC: 30-minute; non-DAC preserves more physiological patterns.
2015